JCO Oncology Advances
ISSN:
2994-9750
Publisher:
Alexandria VA: American Society of Clinical Oncology, [2024]-
Country:
United States
ES-FAC
ES-FAC C
Eurascience Journal Classification System
📄 Articles published in this journal
- Reach, Acceptability, and Effectiveness of Proactive Outreach and Varenicline With Cancer-Focused Counseling for Patients With Cancer: A Pilot Randomized Comparative Effectiveness Trial 2026
- Preoperative Gut Microbiome in Patients With Colorectal Cancer: Potential for Fecal Biomarker–Based Recurrence Risk Prediction 2026
- Building on ECOG-ACRIN E3311 to Strengthen Interpretation of Swallowing Outcomes 2026
- Projecting Individualized Probabilities of Lifetime Total Cancer Risk Across a Population 2026
- Three-Year Update of a Randomized Phase IIb Study of the Individualized Neoantigen Therapy Intismeran Autogene (mRNA-4157, V940) Plus Pembrolizumab Versus Pembrolizumab in Resected Melanoma 2026
- Who Can Benefit From a Cancer Genetic Evaluation? Considerations for Genetic Risk Evaluation and Testing Based on Tumor Type and Pathology 2026
- Long-Term Survival in High-Grade Serous Ovarian Cancer Compared With the General US Population: A 30-Year Landmark Analysis 2026
- Randomized Phase III Trial for Evaluating the Efficacy of Adjuvant Abemaciclib in Patients With Locoregional Recurrence of Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: JCOG2313, AURA Trial 2026
- Nivolumab + Doxorubicin, Vinblastine, and Dacarbazine in HIV-Associated Advanced-Stage Classic Hodgkin Lymphoma 2026
- Systemic Therapy Outcomes for Soft Tissue Leiomyosarcoma Patients in an Era of Next-Generation Sequencing 2026